We analyzed the patient tissue samples for expression of clinical markers of breast cancer (e.g., HER2, estrogen receptor/ER, and progesterone receptor/PR) using tissue microarrays (TMAs) we generated from the patient breast tissue blocks. Here, ERBB2 is linked to breast carcinoma.